Hemophagocytic syndrome after living-related liver transplantation
Makaleler > Tam Makale · 2003
Yazarlar: Abdullah Zeki KARASU, Murat KILIÇ, S. Cagirgan, ELİF LEBE, Funda YILMAZ BARBET, T. Demirbas, YAMAN TOKAT
TRANSPLANTATION PROCEEDINGS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2003, cilt 35, ss 1482-1484
DOI: 10.1016/s0041-1345(03)00511-6
Özet
Hemophagocytic syndrome (HPS) is a life-threatening hematological disorder in immunocompromised patients. Although the number of patients with HPS following liver transplantation is scarce the outcome is usually fatal. We report a patient who developed HPS following living-related liver transplantation (LRLT) and was treated successfully by a combination of intravenous (IV) immunoglobulin (Ig) and granulocyte colony-stimulating factor (GCSF).